During the past decade, Klinikum Kulmbach conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Kulmbach" #1 sponsor was "AGO Research GmbH" with 1 trials, followed by "European Breast Cancer Reseach Association of Surgical Trialists" with 1 trials sponsored, "Grupo Español de Investigación en Cáncer de Ovario" with 1 trials sponsored, "Institut fuer Frauengesundheit" with 1 trials sponsored and "Klinikum Coburg" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Kulmbach" #1 collaborator was "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "AGO Breast Study Group e.V." with 1 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator, "AGO-B" with 1 trials as a collaborator and "AWOgyn" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Kulmbach" are "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Advanced Breast Cancer" (1 trials), "Breast Cancer Female" (1 trials) and "Breast Neoplasm Female" (1 trials). Many other conditions were trialed in "Klinikum Kulmbach" in a lesser frequency.

Most popular intervention types in "Klinikum Kulmbach" are "Drug" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Gemcitabine" (1 trials) and "Niraparib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Kulmbach" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Kulmbach". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Kulmbach, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Kulmbach, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".